The document discusses National Health Programmes in India, specifically the National Leprosy Eradication Programme. It notes that various health programmes have been launched since 1947 to improve public health. The National Leprosy Eradication Programme is headed by the Ministry of Health and aims to control and eliminate leprosy through early detection, multi-drug therapy treatment, and reducing stigma. It outlines the history, objectives, strategies, and institutions involved in implementing the programme.
National leprosy eradication program CHNNehaNupur8
Leprosy is a chronic infectious disease caused by ‘Mycobacterium Leprae’ an acid fast , rod shaped bacillus.
The disease mainly affects the skin , the peripheral nerves , mucosa of the upper respiratory tract and also eyes.
Cardinal Features:-
° Hypopigmented patch
° Loss of cutaneous sensation
° Thickened Nerve
° Acid fast bacilli
Leprosy has been regarded by tbe community as a contagious , mutilating and incurable disease.
Leprosy is curable and treatment provided in the early stages averts disability.
Multidrug Therapy (MDT) treatment has been made available by WHO free of charge to all patients worldwide since 1995, and provides a simple yet highly effective cure for all typesof leprosy.
National leprosy eradication program CHNNehaNupur8
Leprosy is a chronic infectious disease caused by ‘Mycobacterium Leprae’ an acid fast , rod shaped bacillus.
The disease mainly affects the skin , the peripheral nerves , mucosa of the upper respiratory tract and also eyes.
Cardinal Features:-
° Hypopigmented patch
° Loss of cutaneous sensation
° Thickened Nerve
° Acid fast bacilli
Leprosy has been regarded by tbe community as a contagious , mutilating and incurable disease.
Leprosy is curable and treatment provided in the early stages averts disability.
Multidrug Therapy (MDT) treatment has been made available by WHO free of charge to all patients worldwide since 1995, and provides a simple yet highly effective cure for all typesof leprosy.
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
Health: “a state of complete physical, mental and social well being and not merely an absence of disease or infirmity”.
Health is fundamental human right and nation has a responsibility for the health of its people.
The health problems of India may be conveniently listed under the following heads:
1. Communicable disease problems
2. Noncommunicable disease problems
2. Nutritional problems
3. Environmental sanitation problems
4. Medical care problems
5. Population problems
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
Human Anatomy and Physiology : Introduction
PCI Syllabus, B. Pharmacy, BP101T
Session VI
Basic life processes, Metabolism, growth, responsiveness, differentiation, movement, reproduction.
Homeostasis. Definition, regulation, feedback system. Disorders, diseases and death. Signs and Symptoms.
Human Anatomy and Physiology : Introduction
PCI Syllabus, B. Pharmacy, BP101T
Session III
Levels of Structural Organization.
Anatomical Nomenclature.
Anatomical terms and their meaning
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
1. Dr Jyoti Prasad Pattnaik
MBBS, PGDMCH, PGDHM
Asst Professor
National Health
Programmes
for Leprosy
1
Dr Jyoti Prasad Pattnaik, MBBS
2. Since independence in 1947
many measures have been taken to
improve the health of the people and
the society at large and the most
effective of all these programmes is
National health Programmes.
2
Dr Jyoti Prasad Pattnaik, MBBS
3. National Health Programmes
These programmes are launched by the central
government from time to time
• To control/eradicate communicable diseases
• Improve environmental sanitation
• Raising the standards of nutrition
• Control of population
• Improving rural health scenario
3
Dr Jyoti Prasad Pattnaik, MBBS
4. International Assistance
• International agencies like WHO,
UNICEF, UNFPA, World Bank
• Foreign aid agencies like SIDA, DANIDA,
NORAD, USAID etc have been providing
technical and material assistance in the
implementation of these programmes.
4
Dr Jyoti Prasad Pattnaik, MBBS
5. Some programmes list…
• Integrated disease surveillance programme
• National leprosy eradication programme
• National tuberculosis programme
• Revised national tb control programme
• National mental health programme
• National AIDS control programme
• National programme for prevention and control of deafness
• Universal immunization programme
• National programme for control of blindness
• Pulse polio programme
5
Dr Jyoti Prasad Pattnaik, MBBS
6. National Leprosy Eradication
Programme
The National Leprosy Eradication Programme is
a centrally sponsored Health Scheme of the Ministry
of Health and Family Welfare, Govt. of India. The
Programme is headed by the Deputy Director of
Health Services (Leprosy ) under the administrative
control of the Directorate General Health Services
Govt. of India.
Dr Jyoti Prasad Pattnaik, MBBS 6
7. While the NLEP strategies and plans are
formulated centrally, the programme is implemented
by the States/UTs. The Programmes also supported
as Partners by the World Health Organization, The
International Federation of Anti-leprosy Associations
(ILEP) and few other Non-Govt. Organizations.
Dr Jyoti Prasad Pattnaik, MBBS 7
8. History
The National Leprosy Control Programme (NLCP) was
launched in 1955 in order to control the number of leprosy infections.
In 1983, the strategies for leprosy control were changed and National
Leprosy Eradication Program was launched. In the same year,
multidrug therapy was also launched. In 1991, the World Health
Assembly resolved to eliminate leprosy at a global level by the year
2000. In order to strengthen the process of elimination in the country,
the first World Bank supported project was introduced in India in 1993
and completed in 2000. The second World Bank supported project
happened between 2001-2002. In 2005, due to the declining number
of leprosy cases, the goal of NLEP was declared as elimination of
leprosy at the national level. In 2009, a special action plan for 209
high endemic districts in 16 states/union territories were made.
Dr Jyoti Prasad Pattnaik, MBBS 8
9. Milestones
• 1955 - National Leprosy Control Programme
(NLCP) launched
• 1983 - National Leprosy Eradication Programme
launched
• 1983 - Introduction of Multidrug therapy (MDT)
in Phases
• 2005 - Elimination of Leprosy at National Level
• 2012 - Special action plan for 209 high
endemic districts in 16 States/UTs
Dr Jyoti Prasad Pattnaik, MBBS 9
10. Objectives
• Early detection through active surveillance by the
trained health workers;
• Regular treatment of cases by providing Multi-Drug
Therapy (MDT) at fixed in or centres a nearby village of
moderate to low endemic areas/district;
• Intensified health education and public awareness
campaigns to remove social stigma attached to the
disease.
• Appropriate medical rehabilitation and leprosy ulcer
care services.
Dr Jyoti Prasad Pattnaik, MBBS 10
11. Strategies
• Decentralized integrated leprosy services through General Health Care system.
• Early detection & complete treatment of new leprosy cases.
• Carrying out house hold contact survey in detection of Multibacillary (MB) & child
cases.
• Early diagnosis & prompt MDT, through routine and special efforts
• Involvement of Accredited Social Health Activists (ASHAs) in the detection &
complete treatment of Leprosy cases for leprosy work
• Strengthening of Disability Prevention & Medical Rehabilitation (DPMR) services.
• Information, Education & Communication (IEC) activities in the community to
improve self-reporting to Primary Health Centre (PHC) and reduction of stigma.
• Intensive monitoring and supervision at Primary Health Centre/Community Health
Centre.
Dr Jyoti Prasad Pattnaik, MBBS 11
12. Institutions
Four premier Leprosy Institutes are working under
Directorate General of Health Services, Ministry of Health &
F.W., Government of India viz. CLTRI, Chengalpattu, RLTRI, at
Aska, Raipur and Gouripur are involved in research (basic and
applied ) in Leprosy and Training of different categories of staff
involved for Leprosy elimination. These Institutes also play
important role in management of referral patients, providing
quality care to chronic ulcer and disabled patients with the help
of Minor & Major Reconstructive Surgeries. These Institutes also
help in supervising and providing consultancy services to the
State NLEP Units for better programme planning and
implementation.
Dr Jyoti Prasad Pattnaik, MBBS 12
13. Regional leprosy training & research institute
(rltri) aska (orissa)
This Institute was established in 1977 with 67
sanctioned posts viz. (Gr. A – 06, Gr. B – 02, Gr. C –
32 and Gr. D – 27) and 53 are in position viz.(Gr. A –
04, Gr. B – 0, Gr. C – 27, and Gr. D - 32). It has a fifty
beded hospital. The in-patient services regularly
admits and treats, leprosy patients . It also works as a
nodal training and research center particularly
programme related research activities in the region for
the cause of leprosy elimination.
Dr Jyoti Prasad Pattnaik, MBBS 13
14. Dr Jyoti Prasad Pattanayak
MBBS, PGDMCH, PGDHM
Asst Professor
Dept of Pharmacology
Roland Institute of Pharmaceutical Sciences
Khodasingi, Berhampur, 760010, Odisha
14
Dr Jyoti Prasad Pattnaik, MBBS